Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PRTG market cap is 4.5M. The company's latest EPS is USD -71.8463 and P/E is -0.06.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.06M | -5.99M | -4.18M | -3.24M | -2.85M |
| Net Income | -5.92M | -5.16M | -39.37M | -24.89M | -1.66M |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.98M | -12.93M | -15.65M | -60.7M | -18.46M |
| Net Income | -5.33M | -15.83M | -16.87M | -104.61M | -75.34M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 98.37M | 92.4M | 49.04M | 7.78M | 5.24M |
| Total Liabilities | 25.72M | 25.4M | 17.71M | 4.45M | 3.43M |
| Total Equity | 72.65M | 67M | 31.33M | 3.33M | 1.81M |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 173.17M | 174.86M | 194.66M | 99.13M | 7.78M |
| Total Liabilities | 27.53M | 27.26M | 29.23M | 23.73M | 4.45M |
| Total Equity | 145.64M | 147.6M | 165.43M | 75.4M | 3.33M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.45M | -7.75M | -11.18M | -14.3M | -1.69M |
| Investing | N/A | N/A | N/A | 2.81M | N/A |
| Financing | 606k | 645k | 5.97M | 5.97M | -8k |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.71M | -4.28M | -6.76M | -12.07M | -14.3M |
| Investing | N/A | -860k | N/A | -617k | 2.81M |
| Financing | 700k | 4.76M | 27.35M | -117k | 5.97M |
| Market Cap | 4.5M |
| Price to Earnings Ratio | -0.06 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.88 |
| Price to Book Ratio | 1.33 |
| Dividend Yield | - |
| Shares Outstanding | 1.05M |
| Average Volume (1 week) | 44.66k |
| Average Volume (1 Month) | 35.69k |
| 52 Week Change | -85.21% |
| 52 Week High | 40.80 |
| 52 Week Low | 2.098 |
| Spread (Intraday) | 0.43 (9.11%) |
| Company Name | Portage Biotech Inc |
| Address |
clarence thomas building road town, tortola VG1110 |
| Website | https://www.portagebiotech.com/ |
| Industry | crude petroleum & natural gs (1311) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
